Recent MSK Discoveries & Advances

Recent MSK Discoveries & Advances

Share
Share

Memorial Sloan Kettering researchers are relentlessly exploring every aspect of cancer — from basic investigations of cells and molecules to clinical trials of new treatments and population-wide studies of the disease. While our core mission is to translate this knowledge into new strategies to control cancer, many of our investigators are also making scientific progress against other diseases and conditions.

Below are some examples of discoveries and advances that recently were made in our laboratories and clinics, and featured in our news stories.

and/or
373 News Items found
In the Clinic
Asia McCoy speaking with a patient
Patient-Reported Side Effects: A Crucial Part of Cancer Clinical Trials
In recent years, there has been a shift toward capturing information about the side effects caused by new treatments directly from patients.
Finding
Alex Kentsis in his lab
Research Uncovers the Genetic Causes of Aggressive Leukemia in Children
Researchers have found that the genetic changes that cause pediatric leukemia are different from those that lead to leukemia in adults.
In the Lab
A cartoon of a person hiding behind a newspaper and sunglasses.
CAR T Cells Get an Invisibility Cloak
Research is focusing on ways to help cancer-fighting immune cells stick around longer, boosting their effectiveness.
In the Lab
Colorful illustration of X and Y chromosome
Y Cancer? New Research Initiative Focuses on the Role of Genes Found on the Male Chromosome
A team from MSK is undertaking new research to study the genes found on the Y chromosome and their role in cancer.
Finding
Side-by-side pictures of tissues from a responder and a non-responder to targeted therapy for kidney cancer
For Kidney Cancer, the Tumor’s Environment May Be Key to Optimizing Treatment
One size does not fit all when it comes to treating renal cell carcinoma.
Q&A
Microscopic image of prostate cancer cells in culture.
Genetic Finding Can Guide Immunotherapy for Prostate Cancer
Genetic sequencing of prostate tumors can identify men who should receive immunotherapy drugs.
In the Lab
Illustration of DNA base pairs
What Was MSK’s Role in TCGA, the Groundbreaking Cancer Genomic Study?
The multicenter project, which yielded dozens of scientific papers on more than 30 different kinds of cancer, has officially drawn to a close.
Roundup
2018
Top 10 Stories of 2018, Cancer Research Edition
Take a look back at some of the year’s biggest news in cancer research.
In the Lab
electron micrograph of a natural killer cell
Drugs That Stall — But Don’t Kill — Cancer Cells Are an Untapped Resource, Study Suggests
A drug combination that halts tumor cell division can stir the immune system into taking action.
In the Clinic
Kirt Robinson
Kirt’s Story: How a Clinical Trial for a Rare Tumor Gave Me a New Lease on Life
A clinical trial led by MSK sarcoma expert Mrinal Gounder has shown promising results for treating desmoid tumors.